ESMO 2019 Highlights in HR+ HER2− advanced breast cancer: The MONALEESA-3 study

Michelino De Laurentiis reports on key results from ESMO Congress 2019 on LBA7_PR: Overall survival (OS) results of the Phase III MONALEESA-3 trial...
Back to Top